Your browser doesn't support javascript.
loading
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia].
Zhang, X S; Liu, B C; Du, X; Zhang, Y L; Xu, N; Liu, X L; Li, W M; Lin, H; Liang, R; Chen, C Y; Huang, J; Yang, Y F; Zhu, H L; Pan, L; Wang, X D; Li, G H; Liu, Z G; Zhang, Y Q; Liu, Z F; Hu, J D; Liu, C S; Li, F; Yang, W; Meng, L; Han, Y Q; Lin, L E; Zhao, Z Y; Tu, C Q; Zheng, C F; Bai, Y L; Zhou, Z P; Chen, S N; Qiu, H Y; Yang, L J; Sun, X L; Sun, H; Zhou, L; Liu, Z L; Wang, D Y; Guo, J X; Pang, L P; Zeng, Q S; Suo, X H; Zhang, W H; Zheng, Y J; Jiang, Q.
Afiliação
  • Zhang XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Liu BC; National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
  • Du X; The Second People's Hospital of Shenzhen, Shenzhen 518035, China.
  • Zhang YL; Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Xu N; Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Liu XL; Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Li WM; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Lin H; First Hospital of Jilin University, Changchun 130021, China.
  • Liang R; Xijing Hospital, Airforce Military Medical University, Xi'an 710032, China.
  • Chen CY; Qilu Hospital of Shandong University, Jinan 250012, China.
  • Huang J; The Fourth Affiliated Hospital of Zhejiang University, Hangzhou 322000, China.
  • Yang YF; Institute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhu HL; Institute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Pan L; Institute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Wang XD; Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Chengdu 610072, China.
  • Li GH; Xi'an International Medical Center Hospital, Xi'an 710038, China.
  • Liu ZG; Shengjing Hospital of China Medical University, Shenyang 110020, China.
  • Zhang YQ; The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
  • Liu ZF; The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Hu JD; Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Liu CS; First Hospital of Jilin University, Changchun 130021, China.
  • Li F; The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Yang W; Shengjing Hospital of China Medical University, Shenyang 110020, China.
  • Meng L; Tongji Hospital of Tongji Medical College, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
  • Han YQ; The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China.
  • Lin LE; Hainan General Hospital, Haikou 570311, China.
  • Zhao ZY; Hainan General Hospital, Haikou 570311, China.
  • Tu CQ; Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen 518101, China.
  • Zheng CF; Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen 518101, China.
  • Bai YL; Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China.
  • Zhou ZP; The Second Hospital Affiliated to Kunming Medical University, Kunming 650106, China.
  • Chen SN; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou 215006, China.
  • Qiu HY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou 215006, China.
  • Yang LJ; Xi'an International Medical Center Hospital, Xi'an 710117, China.
  • Sun XL; The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
  • Sun H; The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Zhou L; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Liu ZL; Huazhong University of Science and Technology Union Shenzhen Hospital, Nanshan Hospital, Shenzhen 518000, China.
  • Wang DY; Huazhong University of Science and Technology Union Shenzhen Hospital, Nanshan Hospital, Shenzhen 518000, China.
  • Guo JX; The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
  • Pang LP; Peking University Shenzhen Hospital, Shenzhen 516473, China.
  • Zeng QS; The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Suo XH; Handan Central Hospital, Handan 057150, China.
  • Zhang WH; First Hospital of Shangxi Medical University, Taiyuan 300012, China.
  • Zheng YJ; First Hospital of Shangxi Medical University, Taiyuan 300012, China.
  • Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhonghua Xue Ye Xue Za Zhi ; 44(9): 728-736, 2023 Sep 14.
Article em Zh | MEDLINE | ID: mdl-38049316
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Antineoplásicos Limite: Adolescent / Adult / Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Antineoplásicos Limite: Adolescent / Adult / Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article